Nicox

en fr

About Us
Pipeline, Markets and Science
Investors
News and Events
Contact Us

Nicox’s lead anti-inflammatory drug candidate HCT-1026 advances in development

December 4, 1996

← Back to blog page

Nicox

Contact Us
Subscribe to news
Legal Notice

Search

© Copyright Nicox, all rights reserved

Cookies

By continuing to use this website, you agree to our Cookie Policy.